Search Results - "Fredrick, L.M"

Comparison of efficacy and safety of ombitasvir/paritaprevir/ ritonavir and dasabuvir ± ribavirin between Asian and western HCV GT1b-infected patients by Wei, L, Luo, Y, Chuang, W.-L, Paik, S.W, Yu, M.-L, Fredrick, L.M, Campbell, A, Trinh, R, Enejosa, J, Shulman, N.S, Heo, J, Mobashery, N

Get full text

Impact of hepatoprotective medications on the safety and efficacy of ombitasvir/paritaprevir/ritonavir and dasabuvir ± ribavirin in hepatitis C virus genotype lb-infected Asian patients with and without cirrhosis in the ONYX-I and -II studies by Chuang, W.-L, Luo, Y, Heo, J, Wang, G.-Q, Yu, M.-L, Kim, Y.J, Xie, Q, Peng, C.-Y, Zhang, M, Huang, Y, Lu, W, Fredrick, L.M, Mobashery, N, Wei, L

Get full text

Efficacy and safety of Ombitasvir/paritaprevir/ritonavir and dasabuvir in non-cirrhotic Asian patients with genotype 1b chronic hepatitis C virus infection: ONYX-I post-treatment week 24 results by Wei, L, Hou, J, Luo, Y, Heo, J, Chu, C.-J, Duan, Z, Cho, M, Cheng, J, Li, J, Jia, J, Lu, W, Fredrick, L.M, Pilot-Matias, T, Mobashery, N, Chuang, W.-L

Get full text

Efficacy and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir with ribavirin in adults with genotype 1 or genotype 4 chronic hepatitis C virus infection and child-pugh B decompensated cirrhosis by Mantry, P, Reddy, R, Cohen, E, Everson, G, Ramji, A, Zeuzem, S, Gordon, S, Yoshida, E, Sherman, M, Balart, L, Baumgarten, A, Lee, S, Fredrick, L.M, Abunimeh, M, Cohen, D.E, Shulman, N.S, Wilson, J

Get full text

FRI-271 - Comparison of efficacy and safety of ombitasvir/paritaprevir/ ritonavir and dasabuvir ± ribavirin between Asian and western HCV GT1b-infected patients by Wei, L., Luo, Y., Chuang, W.-L., Paik, S.W., Yu, M.-L., Fredrick, L.M., Campbell, A., Trinh, R., Enejosa, J., Shulman, N.S., Heo, J., Mobashery, N.

Get full text

SAT-251 - Efficacy and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir with ribavirin in adults with genotype 1 or genotype 4 chronic hepatitis C virus infection and child-pugh B decompensated cirrhosis by Mantry, P., Reddy, R., Cohen, E., Everson, G., Ramji, A., Zeuzem, S., Gordon, S., Yoshida, E., Sherman, M., Balart, L., Baumgarten, A., Lee, S., Fredrick, L.M., Abunimeh, M., Cohen, D.E., Shulman, N.S., Wilson, J.

Get full text

FRI-273 - Efficacy and safety of Ombitasvir/paritaprevir/ritonavir and dasabuvir in non-cirrhotic Asian patients with genotype 1b chronic hepatitis C virus infection: ONYX-I post-treatment week 24 results by Wei, L., Hou, J., Luo, Y., Heo, J., Chu, C.-J., Duan, Z., Cho, M., Cheng, J., Li, J., Jia, J., Lu, W., Fredrick, L.M., Pilot-Matias, T., Mobashery, N., Chuang, W.-L.

Get full text

SAT-291 - Impact of hepatoprotective medications on the safety and efficacy of ombitasvir/paritaprevir/ritonavir and dasabuvir ± ribavirin in hepatitis C virus genotype lb-infected Asian patients with and without cirrhosis in the ONYX-I and -II studies by Chuang, W.-L., Luo, Y., Heo, J., Wang, G.-Q., Yu, M.-L., Kim, Y.J., Xie, Q., Peng, C.-Y., Zhang, M., Huang, Y., Lu, W., Fredrick, L.M., Mobashery, N., Wei, L.

Get full text

HRQoL improves in treatment-naïve HIV-1 subjects initiated on lopinavir/ritonavir by Baran, R.W, Dietz, B, Fredrick, L.M, Tian, M, Podsadecki, T

“…7?11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK…”
Get full text